Vivotecnia Overview

  • Founded
  • 2000
Founded
  • Status
  • Private
  • Employees
  • 177
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 3

Vivotecnia General Information

Description

Provider of preclinical contract research services intended to assist in preclinical product development and product safety studies. The company's services include preclinical studies of toxicology, genotoxicity, carcinogenicity and safety pharmacology, enabling pharmaceutical industries, biotech companies and agrochemical industries to achieve their goals and ensure that their study is developed optimally, cost-effectively, ethically and in compliance with regulatory requirements.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Laboratory Services (Healthcare)
Primary Office
  • Parque Científico de Madrid
  • Santiago Grisolía, 2 Tres Cantos
  • 28760 Madrid
  • Spain
+34 917 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivotecnia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC Completed Generating Revenue
1. Buyout/LBO (MBO) 01-May-2007 00.000 00.000 Completed Generating Revenue
To view Vivotecnia’s complete valuation and funding history, request access »

Vivotecnia Executive Team (9)

Name Title Board Seat Contact Info
Andres Konig Ph.D Founder, Chief Executive Officer & Chairman
Raul Velazquez Managing Director
Silvia Fernandez Director and Manager, Animal Facilities & Operations
Francisco Monreal Director, Quality Assurance
Felix Risco Director, Research
You’re viewing 5 of 9 executive team members. Get the full list »

Vivotecnia Board Members (1)

Name Representing Role Since
Andres Konig Ph.D Vivotecnia Founder, Chief Executive Officer & Chairman 000 0000
To view Vivotecnia’s complete board members history, request access »

Vivotecnia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vivotecnia Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Clave Venture Capital Majority 000 0000 000000 0
Mobius Corporate Venture Capital Venture Capital Majority 000 0000 000000 0
Tibidabo Ventures Venture Capital Minority 000 0000 000000 0
To view Vivotecnia’s complete investors history, request access »